Additional file 1: of Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients

Angela Salvino (3518600); Anna Di Vito (3518612); Annalisa Di Cello (3518609); Antonia Rizzuto (849202); Carmela De Marco (184139); Caterina Camastra (849200); Chiara Mignogna (849203); Cirino Botta (3518597); Giuseppe Donato (575751); Ivan Presta (324732); Michele Morelli (3518606); Natalia Malara (2078854); Nicoletta Staropoli (3518603); Pierfrancesco Tassone (525648); Pierosandro Tagliaferri (525647); Renato Franco (184143); Tullio Barni (2141623)

Additional file 1: of Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients

Authors: Angela Salvino (3518600)
Anna Di Vito (3518612)
Annalisa Di Cello (3518609)
Antonia Rizzuto (849202)
Carmela De Marco (184139)
Caterina Camastra (849200)
Chiara Mignogna (849203)
Cirino Botta (3518597)
Giuseppe Donato (575751)
Ivan Presta (324732)
Michele Morelli (3518606)
Natalia Malara (2078854)
Nicoletta Staropoli (3518603)
Pierfrancesco Tassone (525648)
Pierosandro Tagliaferri (525647)
Renato Franco (184143)
Tullio Barni (2141623)
Publication date
Publisher
Doi

Abstract

Figure S1. Correlation of platinum sensitivity status with survival. Kaplan Meier curves of EOC patients grouped according to platinum sensitive (PS) or resistant (PR) disease. Patients with a platinum sensitive ovarian cancer presents a significant longer survival thus confirming the reliability of the sample. (JPG 182 kb

Similar works

Full text

Available Versions

FigShare

oai:figshare.com:article/44108...

Last time updated on 12/02/2018